Calnexin antibody and other organelle markers: a reference or a readout

Organelle markers are used for two quite different purposes and confused between them constantly: as a reference that says which compartment a fraction or an image region is, and as a readout of an organelle's behaviour. The first is a control and the second is an experiment, and reading a control as an experiment produces some of the most persistent errors in cell biology. This page separates them.

how an autophagy marker is read, never as a single level
a ratio
the authentication guidance a funded study is expected to follow
NIH rigor
the containment human cell lines in the experiment are handled at
BSL-2

Figures in this panel are the validation and labelling rules a research antibody is bought and used under, named from the guidance itself and linked in the sources below. They are identifiers, not prices: BioBricks publishes verified prices for synthesis services only, and does not imply a reagent price index it has not measured.

Using organelle markers correctly

  1. Use a compartment marker as a reference, not as a quantity. An endoplasmic reticulum marker tells you a fraction contains that compartment or an image region is that compartment. It does not measure how much endoplasmic reticulum a cell has, and treating a change in marker level as a change in organelle content requires far more evidence than a blot.
  2. Run the full marker panel on a fractionation. A fraction is characterised by what is enriched and by what is depleted, so markers for the other compartments have to be blotted alongside. A fraction claimed to be one organelle with only that organelle's marker shown is an unverified claim.
  3. Read LC3 as a conversion, not as a level. The autophagy marker exists as a soluble and a lipidated form that run at different sizes, and the ratio between them is the readout. Both an increase in autophagy and a block in degradation raise the lipidated form, which is why the measurement requires a lysosomal inhibitor arm.
  4. Load equally and normalise to total protein. For markers used as loading or fractionation references, total protein staining of the membrane is a better normaliser than another single protein, because a single reference can itself change with treatment.
  5. Validate the marker in your own cell type. Organelle marker abundance varies widely between cell types, and a marker that is strong in a secretory cell may be faint elsewhere. Establish the expected pattern in an untreated sample before interpreting any change.

Imaging colocalisation without overclaiming

Two markers appearing in the same pixel at diffraction-limited resolution is not contact, let alone interaction. Report a colocalisation coefficient with the method named, and include a control pair known not to colocalise so the coefficient has a floor.

Chromatic aberration shifts channels relative to each other by more than people expect. Image multicolour beads and correct for the shift before measuring anything.

Fixation choices that destroy the structure

Methanol fixation preserves some epitopes and disrupts membranes, which for an organelle marker is a serious trade. Aldehyde fixation preserves structure and can mask epitopes. Test both on a known positive and choose on the structure, not only the signal.

For live imaging of these compartments, genetically encoded markers or dyes answer the question without fixation, and they answer a dynamic question a fixed image cannot.

Buying and recording

Prefer a clone with published images in your cell type, and buy a single lot for a study. For markers used as references across many experiments, a recombinant reagent that will not vary is worth the premium.

Record catalogue number, lot, dilution and the fixation used. For organelle markers the fixation is part of the reagent's identity in practice, and a method without it cannot be repeated.

A PIP2 antibody and other lipid epitopes need a different protocol entirely

Antibodies against phosphoinositides and other lipids are affected by every step that extracts lipid: the fixation, the permeabilisation agent and the detergent. The permeabilisation most laboratories use by default removes much of the target, which is why lipid staining protocols specify their own reagents and are not interchangeable with protein ones.

The negative control is different too. A knockout is usually impossible, so the control is an enzymatic or chemical treatment that removes the epitope, or inhibition of the pathway that produces it, run alongside the sample. Designing that control before the experiment is what makes the staining interpretable at all.

14-3-3 antibody reagents and families of near-identical proteins

Some abundant adaptor families consist of several proteins that are very similar in sequence and identical in size on a gel. Many antibodies sold against one member detect several, which is perfectly acceptable where the experiment concerns the family, provided the claim matches the reagent.

Problems arise when a family-wide reagent supports a claim about one member. There the evidence has to be a reagent shown to discriminate, or a different approach entirely; nothing about a single band establishes which member produced it.

Sub-compartments: a Golgi marker antibody labels part of an organelle

Organelles have sub-domains and many popular markers label one of them. A marker of one face of a stacked organelle will not overlap with a protein resident in another face, and reading that as absence from the organelle is a frequent and avoidable error.

Choose the marker whose distribution matches the question, and confirm its expected pattern in your own cells under your own fixation before using it as a reference. Compartment markers are usually validated in a handful of common lines, and both distribution and epitope accessibility vary more between cell types than product pages suggest.

Unusual requests, such as an rRNA antibody, worth a second look

Occasionally a request names a target that antibodies do not conventionally address, such as a nucleic acid species. Reagents that bind such targets exist, their specificity is harder to establish, and the experiment is usually better served by a hybridisation method aimed at the same question.

The same applies to viral oncoproteins used to characterise transformed lines. The antibody answers whether the protein is present, which is useful alongside proper line authentication, and it answers nothing on its own about where the line came from.

An rna polymerase iii antibody and the complex it detects

RNA polymerase III is a multi subunit enzyme, so an rna polymerase iii antibody names a subunit and the datasheet has to say which, since a change in one subunit does not establish a change in the complex. It is also an autoantibody target in scleroderma, which is a separate clinical test under a similar name. Nuclear and nucleolar staining is the expected pattern.

An e coli antibody and what it is used for

An e coli antibody detects bacterial proteins and is used for contamination checks, for host cell protein assays in a recombinant process and in microbiology, and the three need different products: a polyclonal against a whole lysate for coverage, or a defined target for identification. For a host cell protein assay coverage analysis rather than titre is the specification.

Common questions

What does a calnexin antibody mark?
The endoplasmic reticulum membrane. It is used as an ER reference in fractionation and imaging, and as a loading control in some contexts, rather than as a measure of how much ER a cell contains.
How should an lc3a antibody result be read?
As the ratio between the soluble and lipidated forms, in the presence and absence of a lysosomal degradation block. Without the block, an increase in the lipidated form cannot distinguish more autophagy from less degradation.
Can an endoplasmic reticulum marker antibody be a loading control?
Only if it is genuinely invariant under your treatment, which has to be shown rather than assumed. Total protein normalisation avoids the question and is generally the better answer.
Why does my fractionation look impure?
Because fractionation is enrichment rather than purification, and adjacent compartments co-sediment. Blot the markers for the other compartments and report enrichment, rather than claiming purity nobody achieved.
Can I stain lipids with a standard immunofluorescence protocol?
No. The usual permeabilisation extracts much of the target. Lipid staining protocols specify their own fixation and permeabilisation, and a protein protocol will report an absence that is an artefact of the method.

Get a shortlist for your project

Free. We send a shortlist of vendors whose published prices and service scope fit what you described, built from the verified index on this site. We may email you about this enquiry and similar services from this site; opt out any time, including from the first message.

Browse by service class

Sources

Cite or embed this figure

The median advertised gene synthesis price per base pair in the US research synthesis services market was $0.11 in August 2026, across 4 verified vendor service pages recorded in BioBricks Synthesis Price Index.

Cite as: "BioBricks Synthesis Price Index", updated 2026-08-24, https://biobricks.org/organelle-marker-antibodies/.

Embed this figure (plain HTML, no scripts)
median advertised gene synthesis price per base pair · the US research synthesis services market · August 2026

$0.11

Middle 50%$0.07 – $0.15
verified vendor service pages4

Source: BioBricks Synthesis Price Index

Get a vendor shortlistCompare synthesis prices